Benitec, Inc. (BLT.AX) Announces Acquisition of Tacere Therapeutics, Inc. and Phase I/II Ready Hepatitis C (HCV) Program
10/11/2012 9:00:27 AM
More...
|
Tacere Therapeutics, Inc. Reacquires Rights to Develop and Commercialize its Hepatitis C Compounds in Asia from Oncolys BioPharma
2/4/2011 7:59:03 AM
More...
|
Exiqon A/S Announces Achievement of Primary Milestones in RNAi Project for Tacere Therapeutics, Inc.
9/15/2009 8:46:43 AM
More...
|
Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer Inc. (PFE) To Develop and Commercialize RNAi Hepatitis C Drug
1/7/2008 8:46:39 AM
More...
|
Oncolys BioPharma and Tacere Therapeutics Form Strategic Alliance to Develop RNAi Hepatitis C Drug
6/21/2007 11:24:00 AM
More...
|
Tacere Therapeutics Appoints Vice President, Research And Development
11/14/2006 12:29:13 PM
More...
|
Tacere Therapeutics Secures Financing And Resumes Development Of RNAi Hepatitis C Drug
10/12/2006 11:25:42 AM
More...
|